In light of the above, the purpose of this study is to investigate the prevalence of VRI disorders in patients with RVO and to evaluate the impact of VRI abnormalities on the treatment outcomes of macular edema secondary to RVO using intravitreal anti-VEGF agents. This evidence concerns the gene VEGFA and macular retinal edema.